Myelin Oligodendrocyte Glycoprotein Optic Neuritis in Children
Abstract
Introduction: Optic neuritis is a common presenting feature of paediatric central nervous system demyelinating disease. Pediatric optic neuritis (PON) can present as a unilateral or bilateral acute onset visual loss in children. It occurs in isolation or can be associated with systemic diseases. It has an incidence of two per million children per year and is considered as a different clinical entity compared to adult optic neuritis (AON). This article highlights myelin oligodendrocyte glycoprotein optic neuritis in children and the differences in the course of these two cases. Method: Case report. Results: The first case is a 14-year-old girl who presented to us at the age of 10 with left subacute painless blurring of vision. Funduscopic examination revealed left swollen optic disc with no macula star and right eye optic disc pallor. MRI scans showed demyelinating lesions. The second case was a nine-year-old boy who presented with right painless loss of vision for 1 week with a visual acuity of perception loss. Funduscopic examination showed a blurred margin of the right optic disc with no macula star. MRI brain and spinal cord were suggestive of demyelinating disease. Both cases received high dose intravenous corticosteroid and had good visual recovery. Conclusion: PON often leads to significant visual impairment but typically shows good recovery. An abnormal MRI brain scan at onset or recurring episodes of optic neuritis should prompt clinicians to consider a diagnosis of multiple sclerosis (MS) or neuromyelitis optica (NMO).
Keywords
Full Text:
PDFReferences
Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology. 2009 Jan 20;72(3):232–9.
Pérez-Cambrodí RJ, Gómez-Hurtado Cubillana A, Merino-Suárez ML, Piñero-Llorens DP, Laria-Ochaita C. Optic neuritis in pediatric population: A review in current tendencies of diagnosis and management. J Optom. 2014 Jul;7(3):125–30.
Yeh EA, Graves JS, Benson LA, Wassmer E, Waldman A. Pediatric optic neuritis. Neurology. 2016 Aug 30;87(9 Supplement 2):S53–8.
Alper G, Wang L. Demyelinating Optic Neuritis in Children. J Child Neurol. 2009 Jan 1;24(1):45–8.
Lana-Peixoto MA, Andrade GC de. The clinical profile of childhood optic neuritis. Arq Neuropsiquiatr. 2001 Jun;59(2B):311–7.
Wilejto M, Shroff M, Buncic JR, Kennedy J, Goia C, Banwell B. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology. 2006 Jul 25;67(2):258–62.
Lock JH, Newman NJ, Biousse V, Peragallo JH. Update on pediatric optic neuritis. Curr Opin Ophthalmol. 2019 Nov;30(6):418–25.
El-Dairi MA, Ghasia F, Bhatti MT. Pediatric Optic Neuritis. Int Ophthalmol Clin. 2012;52(3):29–49.
Kowsalya A, Ramalingam U, Chaudhary S, Kumar M. Clinical features and visual outcomes of pediatric optic neuritis in the Indian population: A prospective study. Indian J Ophthalmol. 2023;71(2):637.
Hamid SHM, Whittam D, Mutch K, Linaker S, Solomon T, Das K, et al. What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive.A cross sectional study of 132 patients. J Neurol. 2017 Oct 24;264(10):2088–94.
Martinez-Hernandez E, Sepulveda M, Rostásy K, Höftberger R, Graus F, Harvey RJ, et al. Antibodies to Aquaporin 4, Myelin-Oligodendrocyte Glycoprotein, and the Glycine Receptor α1 Subunit in Patients With Isolated Optic Neuritis. JAMA Neurol. 2015 Feb 1;72(2):187.
Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016 Dec 28;13(1):280.
Bergamaschi R, Tonietti S, Franciotta D, Candeloro E, Tavazzi E, Piccolo G, et al. Oligoclonal bands in Devic’s neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Multiple Sclerosis Journal. 2004 Feb 2;10(1):2–4.
Bonhomme GR, Waldman AT, Balcer LJ, Daniels AB, Tennekoon GI, Forman S, et al. Pediatric optic neuritis: Brain MRI abnormalities and risk of multiple sclerosis. Neurology. 2009 Mar 10;72(10):881–5.
Yılmaz Ü, Gücüyener K, Erin DM, Yazar Z, Gürkaş E, Serdaroǧlu A, et al. Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis. J Child Neurol. 2012 Dec 29;27(12):1517–23.
Yeh EA, Marrie RA, Reginald YA, Buncic JR, Noguera AE, O’Mahony J, et al. Functional-structural correlations in the afferent visual pathway in pediatric demyelination. Neurology. 2014 Dec 2;83(23):2147–52.
Yeh E, Weinstock-Guttman B, Lincoff N, Reynolds J, Weinstock A, Madurai N, et al. Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset. Multiple Sclerosis Journal. 2009 Jul 22;15(7):802–10.
Jayakody H, Bonthius DJ, Longmuir R, Joshi C. Pediatric Optic Neuritis: Does a Prolonged Course of Steroids Reduce Relapses? A Preliminary Study. Pediatr Neurol. 2014 Nov;51(5):721–5.
Kishk NA, Abdelfattah W, Shalaby NM, Shehata HS, Hassan A, Hegazy MI, et al. The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt. BMC Neurol. 2021 Dec 1;21(1).
Copyright (c) 2024 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright © 2016 AMDI Publisher, Universiti Sains Malaysia.
Disclaimer : This website has been updated to the best of our knowledge to be accurate. However, Universiti Sains Malaysia shall not be liable for any loss or damage caused by the usage of any information obtained from this web site.
Best viewed: Mozilla Firefox 4.0 & Google Chrome at 1024 × 768 resolution.